We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 2.25% | 455.00 | 450.00 | 460.00 | 455.00 | 445.00 | 445.00 | 19,365 | 16:06:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 48.35 | 215.67M |
TIDMTSTL
RNS Number : 8681K
Tristel PLC
27 April 2020
TRISTEL plc
("Tristel" or the "Company")
Director Appointment
Tristel plc (AIM: TSTL), a leading manufacturer of infection prevention and contamination control products, announces the appointment of Isabel Napper to the Board as a non-executive director.
Isabel has more than 30 years' experience advising clients in the technology and healthcare/life science sectors, where she has experience leading on business development and managing regulatory issues, governance, risk and strategic change. Isabel was previously a partner at the law firm Mills & Reeve where she acted as legal adviser and company secretary to a number of boards. She is also a non-executive director of AIM quoted SDI Group plc and is chair of its Remuneration Committee.
It is expected that Isabel will join Tristel's Remuneration committee.
Commenting on the appointment, Bruno Holthof, Chairman of Tristel, said: "I am delighted to welcome Isabel to the Board at such an exciting time for the Company. Isabel has extensive board level experience and comes from a legal background with experience within our sector. We look forward to her contribution to the Board and we very much look forward to working with her."
For further information please contact:
Tristel plc Tel: 01638 721 500 Paul Swinney, Chief Executive Officer Liz Dixon, Finance Director Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303 finnCap Tel: 020 7220 0500 Geoff Nash/ Giles Rolls (Corporate Finance) Alice Lane (ECM)
Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.
Isabel Josephine Sutherland Napper (formerly Pokorny, Robinson), 62, holds nil ordinary shares in the Company and nil options. Isabel Napper's current and previous directorships/partnerships are as follows:
Current Directorships/Partnerships:
SDI Group plc
Health Enterprise East Limited
Accloud plc
Former Directorships/Partnerships held in last 5 years:
Mills & Reeve LLP
Eastern Academic Health Science Network
Arthur Rank Hospice Charity
Emmaus Cambridge
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAKKQBDABKDKQB
(END) Dow Jones Newswires
April 27, 2020 02:00 ET (06:00 GMT)
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions